Company Filing History:
Years Active: 1997
Title: Jerald Dee Ingersoll: Innovator in Feline Health
Introduction
Jerald Dee Ingersoll is a notable inventor based in Lincoln, NE (US). He has made significant contributions to the field of veterinary medicine, particularly in the development of vaccines for cats. His innovative work has the potential to improve the health and well-being of feline companions.
Latest Patents
Ingersoll holds a patent for a vaccine designed to protect cats against feline infectious peritonitis (FIP). This invention involves a temperature-sensitive (ts) FIP virus, which exhibits substantially reduced growth at 39 degrees Celsius compared to its growth at 31 degrees Celsius. The patent also covers the use of the ts-FIP virus for oral or intranasal administration to cats, aiming to induce immunity against this serious disease.
Career Highlights
Jerald Dee Ingersoll has dedicated his career to advancing veterinary science. His work at Pfizer Corporation has allowed him to collaborate with leading experts in the field. Ingersoll's innovative approach to vaccine development showcases his commitment to improving animal health.
Collaborations
Ingersoll has worked alongside Jay D Gerber, contributing to the advancement of veterinary vaccines. Their collaboration has focused on developing effective solutions to combat feline diseases.
Conclusion
Jerald Dee Ingersoll's contributions to veterinary medicine, particularly through his patent for a vaccine against feline infectious peritonitis, highlight his dedication to animal health. His work at Pfizer Corporation and collaborations with other experts further emphasize the importance of innovation in improving the lives of pets.